CMA1 and anaphylaxis: There is growing evidence to support the investigation of other biomarkers, such as chymase, carboxypeptidase A3, dipeptidyl peptidase I (DPPI), basogranulin, CCL-2, and platelet activating factor (PAF) in the diagnosis of anaphylaxis.